PPAR
Read More about this categoryShow Less
The peroxisome proliferator-activated receptors (PPARs), belonging to the nuclear receptor superfamily, are a group of nuclear receptor proteins that are composed of three isoforms, including PPARγ, PPARα and PPARδ, encoded by separate genes. PPARs have a modular structure characterized by the presence of two highly conserved domains, including the DNA binding domain (DBD) of two zinc fingers and the ligand binding domain (LBD) of 13 α-helices and a small 4-stranded β-sheet. PPARs are ligand-regulated transcription factors controlling gene expression by binding to specific response elements (PPREs) within promoters, where PPARs bind as heterodimers with a retinoid X receptor and interact with cofactors upon binding leading to the increasing of rate of transcription initiation.
Products Related to PPAR(244)
- GC18151Elafibranor (GFT505)CAS: 923978-27-2Purity: >99.00%
Elafibranor (GFT505) (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively.
- GC82298ATRA-biotinCAS: 2226143-93-5Purity: >98.00%
ATRA-biotin (Biotin-ATRA-conjugate) is a biotin-conjugated ATRA.
- GC82590Chiglitazar sodiumCAS: 2390374-10-2Purity: >98.00%
Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC 50 s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
- GC82675CUDA disodiumPurity: >98.00%
CUDA disodium is a potent inhibitor of soluble epoxide hydrolase (sEH), with IC 50 s of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively [1] . CUDA disodium selectively increases peroxisome proliferator-activated receptor ( PPAR ) alpha activity.
- GC82711D-Arabinopyranose- 13 C 5Purity: >99.50%
D-Arabinopyranose - 13 C 5 is the 13 C-labeled D-Arabinopyranose.
- GC83042Fmoc-leucine-d 10CAS: 1190594-22-9Purity: >99.00%
Fmoc-leucine-d 10 is the deuterium labeled Fmoc-leucine.
- GC83796Palmitoyllactic acidCAS: 7795-58-6Purity: >99.50%
Palmitoyllactic acid is a long-chain fatty acid with lipogenic activity.
- GC84054SchizophyllanCAS: 9050-67-3
Schizophyllan (SPG) is an orally active extracellular β-glucan produced by the fungus Schizophyllum commune.
- GC84060Seladelpar (lysine)CAS: 928821-41-4Purity: >98.00%
Seladelpar (MBX-8025) lysine is an orally active, potent and specific PPARδ agonist with an EC 50 of 2 nM.
- GC84317Troglitazone-d 4CAS: 2749370-85-0Purity: >98.00%
Troglitazone-d 4 is deuterium labeled Troglitazone.
- GC84861PPARα/γ agonist 1Purity: >99.50%
PPARα/γ agonist 1 (compound 5b) is a potent and dual PPARα/γ partial agonist with EC 50 values of 28 nM and 69 nM for PPARα and PPARγ, respectively.
- GC8486323-epi-26-DeoxyacteinCAS: 501938-01-8Purity: >98.50%
23-epi-26-Deoxyactein is a natural and orally active anti-obesity and anti-cancer compound [1] [2] [3] .
- GC10190DG-172 (hydrochloride)CAS: 1361504-77-9Purity: >99.00%
DG-172 (hydrochloride) is a selective PPARβ/δ antagonist, with an IC50 of 27 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC18151 | Elafibranor (GFT505) | 923978-27-2 | >99.00% | |
Elafibranor (GFT505) (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. | ||||
| GC82158 | Amezalpat | 1616372-41-8 | >99.50% | |
Amezalpat is the antagonist for PPARα with IC 50 of 58 nM. | ||||
| GC82298 | ATRA-biotin | 2226143-93-5 | >98.00% | |
ATRA-biotin (Biotin-ATRA-conjugate) is a biotin-conjugated ATRA. | ||||
| GC82590 | Chiglitazar sodium | 2390374-10-2 | >98.00% | |
Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC 50 s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively. | ||||
| GC82675 | CUDA disodium | - | >98.00% | |
CUDA disodium is a potent inhibitor of soluble epoxide hydrolase (sEH), with IC 50 s of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively [1] . CUDA disodium selectively increases peroxisome proliferator-activated receptor ( PPAR ) alpha activity. | ||||
| GC82711 | D-Arabinopyranose- 13 C 5 | - | >99.50% | |
D-Arabinopyranose - 13 C 5 is the 13 C-labeled D-Arabinopyranose. | ||||
| GC82882 | (E)-CLX-0921 | 606932-81-4 | >98.00% | |
(E)-CLX-0921 is the E-isomer of CLX-0921. | ||||
| GC82887 | E0924G | 2909474-29-7 | >99.00% | |
E0924G is an orally active activator for PPARδ with EC 50 of 2.82 μM. | ||||
| GC83042 | Fmoc-leucine-d 10 | 1190594-22-9 | >99.00% | |
Fmoc-leucine-d 10 is the deuterium labeled Fmoc-leucine. | ||||
| GC83796 | Palmitoyllactic acid | 7795-58-6 | >99.50% | |
Palmitoyllactic acid is a long-chain fatty acid with lipogenic activity. | ||||
| GC84054 | Schizophyllan | 9050-67-3 | - | |
Schizophyllan (SPG) is an orally active extracellular β-glucan produced by the fungus Schizophyllum commune. | ||||
| GC84060 | Seladelpar (lysine) | 928821-41-4 | >98.00% | |
Seladelpar (MBX-8025) lysine is an orally active, potent and specific PPARδ agonist with an EC 50 of 2 nM. | ||||
| GC84088 | SKLB102 | 242473-63-8 | >98.00% | |
SKLB102 shows a high affinity with PPARγ. SKLB102 has potent ability to reduce fat deposition and protect liver against non-alcoholic fatty liver disease (NAFLD) through regulating adipocytokine expression and preventing insulin resistance [1] . | ||||
| GC84317 | Troglitazone-d 4 | 2749370-85-0 | >98.00% | |
Troglitazone-d 4 is deuterium labeled Troglitazone. | ||||
| GC84861 | PPARα/γ agonist 1 | - | >99.50% | |
PPARα/γ agonist 1 (compound 5b) is a potent and dual PPARα/γ partial agonist with EC 50 values of 28 nM and 69 nM for PPARα and PPARγ, respectively. | ||||
| GC84863 | 23-epi-26-Deoxyactein | 501938-01-8 | >98.50% | |
23-epi-26-Deoxyactein is a natural and orally active anti-obesity and anti-cancer compound [1] [2] [3] . | ||||
| GC10190 | DG-172 (hydrochloride) | 1361504-77-9 | >99.00% | |
DG-172 (hydrochloride) is a selective PPARβ/δ antagonist, with an IC50 of 27 nM. | ||||
| GC10381 | AUDA | 479413-70-2 | >98.00% | |
Potent epoxide hydrolase inhibitor/PPARα activator | ||||
| GC11152 | Pioglitazone HCl | 112529-15-4 | >99.50% | |
A PPARγ agonist | ||||
| GC11170 | Choline Fenofibrate | 856676-23-8 | >98.00% | |
| GC11318 | Rosiglitazone maleate | 155141-29-0 | >99.50% | |
A PPARγ agonist | ||||
| GC11423 | GW1929 | 196808-24-9 | >99.50% | |
A non-thiazolidinedione activator of PPARγ | ||||
| GC11477 | Darglitazone | 141200-24-0 | >99.00% | |
PPARγ agonist with antidiabetic actions | ||||
| GC11586 | SR 202 | 76541-72-5 | >99.50% | |
SR 202 (SR-202) is a potent and specific PPARγ antagonist. | ||||
